Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report) SVP Corby C. Whitaker sold 55,159 shares of the company's stock in a transaction on Monday, May 6th. The shares were sold at an average price of $25.01, for a total value of $1,379,526.59. Following the sale, the senior vice president now owns 131,533 shares of the company's stock, valued at $3,289,640.33. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.
Aspen Aerogels Stock Up 1.4 %
Shares of NYSE:ASPN opened at $26.64 on Thursday. The firm has a market cap of $2.03 billion, a P/E ratio of -60.55 and a beta of 1.97. Aspen Aerogels, Inc. has a 12-month low of $5.32 and a 12-month high of $27.09. The business has a fifty day simple moving average of $17.27 and a 200 day simple moving average of $14.13. The company has a quick ratio of 3.29, a current ratio of 4.01 and a debt-to-equity ratio of 0.24.
Aspen Aerogels (NYSE:ASPN - Get Free Report) last posted its quarterly earnings data on Tuesday, February 13th. The construction company reported ($0.01) EPS for the quarter, topping analysts' consensus estimates of ($0.12) by $0.11. Aspen Aerogels had a negative return on equity of 6.35% and a negative net margin of 10.73%. The company had revenue of $84.22 million for the quarter, compared to analyst estimates of $83.82 million. During the same period in the previous year, the firm earned ($0.20) earnings per share. Analysts predict that Aspen Aerogels, Inc. will post 0.03 earnings per share for the current year.
Institutional Inflows and Outflows
Look Who Fired the World’s Richest Man
From Banyan Hill Publishing | Ad
This company is tiny… but already has contracts with 30 federal agencies and services some of the biggest companies in the U.S.
And demand for the technology is unprecedented … “unlike anything we have seen in the past,” says a spokesman.
Get the full story here.
Institutional investors have recently added to or reduced their stakes in the company. Banque Cantonale Vaudoise lifted its stake in shares of Aspen Aerogels by 37.5% in the first quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company's stock valued at $81,000 after buying an additional 1,252 shares in the last quarter. Thompson Davis & CO. Inc. boosted its stake in Aspen Aerogels by 14.7% during the 4th quarter. Thompson Davis & CO. Inc. now owns 24,150 shares of the construction company's stock valued at $381,000 after purchasing an additional 3,100 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Aspen Aerogels by 38.5% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 12,971 shares of the construction company's stock worth $205,000 after purchasing an additional 3,607 shares during the last quarter. Bouvel Investment Partners LLC lifted its holdings in shares of Aspen Aerogels by 4.3% in the fourth quarter. Bouvel Investment Partners LLC now owns 94,318 shares of the construction company's stock valued at $1,488,000 after purchasing an additional 3,929 shares in the last quarter. Finally, Mitsubishi UFJ Kokusai Asset Management Co. Ltd. grew its holdings in Aspen Aerogels by 7.1% during the third quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 84,257 shares of the construction company's stock worth $725,000 after buying an additional 5,611 shares in the last quarter. 97.64% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several research firms recently weighed in on ASPN. TheStreet raised shares of Aspen Aerogels from a "d+" rating to a "c-" rating in a research report on Wednesday, March 6th. B. Riley upped their price target on shares of Aspen Aerogels from $24.00 to $30.00 and gave the stock a "buy" rating in a report on Friday, May 3rd. HC Wainwright lifted their price objective on shares of Aspen Aerogels from $20.00 to $25.00 and gave the company a "buy" rating in a research note on Friday, May 3rd. Canaccord Genuity Group upped their target price on Aspen Aerogels from $18.00 to $28.00 and gave the stock a "buy" rating in a research note on Friday, May 3rd. Finally, Piper Sandler lifted their price target on Aspen Aerogels from $20.00 to $29.00 and gave the company an "overweight" rating in a research note on Friday, May 3rd. One investment analyst has rated the stock with a sell rating and six have issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $25.17.
Get Our Latest Analysis on Aspen Aerogels
Aspen Aerogels Company Profile
(
Get Free Report)
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
